SCHEMBL15946340

SCHEMBL15946340

Cc1ccc2nc(-c3ccc4nc(-c5ccc(NS(=O)(=O)c6ccccc6)cc5)sc4c3)sc2c1S(=O)(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.68
HPGD P15428 8/20 0.68
MAPT P10636 8/20 0.59
GAA P10253 6/20 0.59
KDM4E B2RXH2 6/20 0.59
GLA P06280 5/20 0.59
RORC P51449 5/20 0.59
SMN1; SMN2 Q16637 7/20 0.59
NPC1 O15118 6/20 0.59
RAB9A P51151 5/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
LMNA P02545 3/20 0.59
TP53 P04637 2/20 0.57
CYP3A4 P08684 1/20 0.57
NT5E P21589 1/20 0.57
CASP1 P29466 1/20 0.57
RECQL P46063 1/20 0.57
CASP7 P55210 1/20 0.57
HSD17B10 Q99714 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14768730 0.89 HPGD (0.58) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL14768724 0.86 ALDH1A1 (0.58) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL15946348 0.85 ALDH1A1 (0.57) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL15946347 0.85 ALDH1A1 (0.57) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL15939872 0.84 MMP2 (0.60) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL15940266 0.82 ALDH1A1 (0.61) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL14768719 0.82 SMN1; SMN2 (0.61) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL14768678 0.81 ALDH1A1 (0.59) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL14768668 0.81 GAA (0.86) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL10605029 0.81 GAA (0.86) ALDH1A1HPGDMAPTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464064-B2 HCV helicase inhibitors and methods of use thereof UNIVERSITY OF KANSAS (US) 2016-10-11 US disclosed
US-20140227225-A1 HCV Helicase Inhibitors and Methods of Use Thereof UWM RESEARCH FOUNDATION, INC. (US) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140227225-A1 HCV Helicase Inhibitors and Methods of Use Thereof DHX15, DDX5, DHX35 ALDH1A1 1138/4885HPGD 653/4885MAPT 2466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.